Crescendo Biologics Limited (06425006) is a private limited with share capital incorporated on 13/11/2007 (18 years old) and registered in cambridge, CB12JH. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Crescendo biologics limited is a biotechnology company based out of meditrina building babraham research campus, cambridge, united kingdom.
Termination Director Company With Name Termination Date
Category:Officers
Date:06-02-2025
Termination Director Company With Name Termination Date
Category:Officers
Date:06-02-2025
Termination Director Company With Name Termination Date
Category:Officers
Date:06-02-2025
Termination Director Company With Name Termination Date
Category:Officers
Date:06-02-2025
Legacy
Category:Capital
Date:16-12-2024
Capital Statement Capital Company With Date Currency Figure
Category:Capital
Date:16-12-2024
Legacy
Category:Insolvency
Date:16-12-2024
Resolution
Category:Resolution
Date:16-12-2024
Capital Allotment Shares
Category:Capital
Date:16-12-2024
Capital Cancellation Shares
Category:Capital
Date:13-12-2024
Capital Name Of Class Of Shares
Category:Capital
Date:13-12-2024
Capital Variation Of Rights Attached To Shares
Category:Capital
Date:13-12-2024
Capital Return Purchase Own Shares
Category:Capital
Date:13-12-2024
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:28-11-2024
Capital Allotment Shares
Category:Capital
Date:26-11-2024
Capital Allotment Shares
Category:Capital
Date:11-09-2024
Appoint Person Secretary Company With Name Date
Category:Officers
Date:11-09-2024
Accounts With Accounts Type Full
Category:Accounts
Date:30-08-2024
Capital Allotment Shares
Category:Capital
Date:23-08-2024
Second Filing Of Confirmation Statement With Made Up Date
Category:Confirmation Statement
Date:21-08-2024
Mortgage Satisfy Charge Full
Category:Mortgage
Date:09-08-2024
Termination Director Company With Name Termination Date
Category:Officers
Date:07-08-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:07-08-2024
Capital Allotment Shares
Category:Capital
Date:28-06-2024
Capital Name Of Class Of Shares
Category:Capital
Date:22-05-2024
Capital Variation Of Rights Attached To Shares
Category:Capital
Date:22-05-2024
Capital Cancellation Shares
Category:Capital
Date:21-05-2024
Capital Return Purchase Own Shares
Category:Capital
Date:21-05-2024
Capital Allotment Shares
Category:Capital
Date:20-02-2024
Second Filing Capital Allotment Shares
Category:Capital
Date:07-12-2023
Second Filing Capital Allotment Shares
Category:Capital
Date:24-11-2023
Capital Name Of Class Of Shares
Category:Capital
Date:08-11-2023
Capital Variation Of Rights Attached To Shares
Category:Capital
Date:08-11-2023
Capital Cancellation Shares
Category:Capital
Date:08-11-2023
Capital Return Purchase Own Shares
Category:Capital
Date:08-11-2023
Capital Allotment Shares
Category:Capital
Date:02-11-2023
Capital Allotment Shares
Category:Capital
Date:17-10-2023
Accounts With Accounts Type Full
Category:Accounts
Date:08-09-2023
Capital Variation Of Rights Attached To Shares
Category:Capital
Date:22-08-2023
Capital Name Of Class Of Shares
Category:Capital
Date:22-08-2023
Capital Return Purchase Own Shares
Category:Capital
Date:22-08-2023
Capital Cancellation Shares
Category:Capital
Date:16-08-2023
Capital Allotment Shares
Category:Capital
Date:15-08-2023
Termination Secretary Company With Name Termination Date
Category:Officers
Date:02-08-2023
Mortgage Create With Deed With Charge Number Charge Creation Date
Category:Mortgage
Date:26-07-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:19-07-2023
Resolution
Category:Resolution
Date:20-06-2023
Capital Allotment Shares
Category:Capital
Date:01-06-2023
Termination Secretary Company With Name Termination Date
Category:Officers
Date:01-06-2023
Appoint Person Secretary Company With Name Date
Category:Officers
Date:01-06-2023
Change Corporate Director Company With Change Date
Category:Officers
Date:09-01-2023
Accounts With Accounts Type Full
Category:Accounts
Date:26-08-2022
Capital Allotment Shares
Category:Capital
Date:29-07-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:13-07-2022
Capital Allotment Shares
Category:Capital
Date:27-06-2022
Capital Allotment Shares
Category:Capital
Date:22-04-2022
Resolution
Category:Resolution
Date:02-04-2022
Capital Allotment Shares
Category:Capital
Date:04-02-2022
Resolution
Category:Resolution
Date:03-02-2022
Capital Allotment Shares
Category:Capital
Date:26-11-2021
Capital Allotment Shares
Category:Capital
Date:26-11-2021
Appoint Person Secretary Company With Name Date
Category:Officers
Date:12-10-2021
Termination Secretary Company With Name Termination Date
Category:Officers
Date:12-10-2021
Accounts With Accounts Type Full
Category:Accounts
Date:19-08-2021
Capital Allotment Shares
Category:Capital
Date:12-07-2021
Confirmation Statement With Updates
Category:Confirmation Statement
Date:09-07-2021
Capital Allotment Shares
Category:Capital
Date:02-07-2021
Resolution
Category:Resolution
Date:14-06-2021
Memorandum Articles
Category:Incorporation
Date:18-03-2021
Capital Allotment Shares
Category:Capital
Date:12-03-2021
Capital Allotment Shares
Category:Capital
Date:17-01-2021
Accounts With Accounts Type Full
Category:Accounts
Date:09-10-2020
Capital Allotment Shares
Category:Capital
Date:21-09-2020
Confirmation Statement With Updates
Category:Confirmation Statement
Date:14-07-2020
Capital Allotment Shares
Category:Capital
Date:22-04-2020
Capital Allotment Shares
Category:Capital
Date:03-04-2020
Capital Cancellation Shares
Category:Capital
Date:11-02-2020
Second Filing Capital Allotment Shares
Category:Capital
Date:11-02-2020
Capital Allotment Shares
Category:Capital
Date:21-01-2020
Capital Return Purchase Own Shares
Category:Capital
Date:17-01-2020
Capital Variation Of Rights Attached To Shares
Category:Capital
Date:28-10-2019
Capital Name Of Class Of Shares
Category:Capital
Date:28-10-2019
Innovate Grants
1
This company received a grant of £137612.0 for Next Generation Adc Therapeutics: Improved Potency & Safety For Treating Cancer. The project started on 01/08/2015 and ended on 31/10/2016.
Import / Export
Imports
12 Months0
60 Months33
Exports
12 Months0
60 Months3
Risk Assessment
low risk
International Score
Future Factor
good
Performance Rating
Accounts
Typetotal exemption full
Due Date30/09/2026
Filing Date30/08/2025
Latest Accounts31/12/2024
Trading Addresses
50-60 Station Road, Cambridge, CB12JHRegistered
Meditrina Building Babraham Researc, Campus, Cambridge Place, Cambridge, Cambridgeshire, CB223AT